These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6320933)

  • 21. Inhibition of NK and ADCC activity by antibodies against purified cytoplasmic granules from rat LGL tumors.
    Reynolds CW; Reichardt D; Henkart M; Millard P; Henkart P
    J Leukoc Biol; 1987 Dec; 42(6):642-52. PubMed ID: 3316462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Utilization of "anti-serum specific" immune serums for the study of abnormal circulating proteins (in acute leukemia, Hodgkin's disease and disseminated lupus erythematosus)].
    CAETANO JA; da COSTA S; SOARES AD; da SILVA J
    Gaz Med Port; 1960; 13():575-82. PubMed ID: 13689743
    [No Abstract]   [Full Text] [Related]  

  • 23. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
    Flavell DJ; Wright DH
    Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H; Morito T; Tanimoto K; Horiuchi Y
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of serum from patients with systemic lupus erythematosus on the immune response of normal lymphocytes.
    Jarrett MP; Grayzel AI
    J Rheumatol; 1985 Feb; 12(1):81-6. PubMed ID: 3981521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical significance of protein-bound hydroxyproline fractions in sera of patients with adult rheumatoid arthritis.
    Rosano CL; Parhami N; Hurwitz C
    J Rheumatol; 1979; 6(6):656-63. PubMed ID: 529249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoelectron microscopic application of monoclonal antibodies for identification of lymphocyte subsets bearing tubuloreticular inclusions or parallel tubular arrays.
    Kang YH; Yaffe L; Grimley PM
    J Exp Pathol; 1984; 1(2):157-73. PubMed ID: 6100980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Sagher D; Karrison T; Schwartz JL; Larson RA; Strauss B
    Cancer Res; 1989 Oct; 49(19):5339-44. PubMed ID: 2548719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
    Ytterberg SR; Schnitzer TJ
    Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virus.
    List AF; Greer JP; Cousar JB; Stein RS; Flexner JM; Sinangil F; Davis J; Volsky DJ; Purtilo DT
    Ann Intern Med; 1986 Nov; 105(5):668-73. PubMed ID: 3021036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations in the ultrastructure of large granular lymphocytes (LGL-NK) in normal and rheumatoid blood.
    Gabrielescu E; Moraru I; Olinescu A; Stoicescu M; Butur G; Nicolau N; Hristescu S
    Morphol Embryol (Bucur); 1987; 33(4):261-8. PubMed ID: 2961985
    [No Abstract]   [Full Text] [Related]  

  • 35. [Large, granular lymphocytes, a new population of mononuclear blood cells].
    Gastl G; Niederwieser D; Huber C
    Wien Klin Wochenschr; 1983 Mar; 95(5):154-8. PubMed ID: 6602424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum factors which suppress natural cytotoxicity in cancer patients.
    Holmes E; Sibbitt WL; Bankhurst AD
    Int Arch Allergy Appl Immunol; 1986; 80(1):39-43. PubMed ID: 3957445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-surface modifications of normal human peripheral lymphocytes induced by lymphocytotoxic sera of patients with systemic lupus erythematosus and Hodgkin's disease, studied by scanning electron microscopy.
    Del Giacco GS; Riva A; Loy M; Batzella MG; Cengiarotti L; Leone AL; Locci F; Murru V
    Haematologica; 1979 Apr; 64(2):148-58. PubMed ID: 112006
    [No Abstract]   [Full Text] [Related]  

  • 38. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferritin deposits in peripheral blood lymphocytes of Hodgkin's disease patients.
    Ben-Bassat I; Ramot B; Aghai E; Djaldetti M
    Acta Haematol; 1979; 62(5-6):267-72. PubMed ID: 121668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-dependent lymphocytotoxicity induced by immunoglobulin G from Hodgkin's disease splenic lymphocytes.
    Longmire RL; Ryan S; McMillan R; Lightsey A; Heath V
    Science; 1978 Jan; 199(4324):71-2. PubMed ID: 17569485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.